BTIG analyst Marie Thibault raised the firm’s price target on iRhythm (IRTC) to $135 from $120 and keeps a Buy rating on the shares after its ...

In a report released yesterday, Julian Harrison from BTIG maintained a Buy rating on Zealand Pharma (ZLDPF – Research Report), with a price ...

Rhumbline Advisers grew its holdings in MercadoLibre, Inc. (NASDAQ:MELI – Free Report) by 3.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm ...

The eatertainment brand saw same-store sales fall 7.7% last quarter, and failed to maintain a leverage ratio required by a financing covenant.

Rhythm (Nasdaq: IRTC) shares got a boost today on fourth-quarter results that came in ahead of the consensus forecast on Wall ...